2009-APBINCT01185132
Intensity Modulated Radiotherapy (IMRT) vs. 3D-conformal Accelerated Partial Breast Irradiation (APBI) for Early Stage Breast Cancer After Lumpectomy
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 6 versions: 5 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗
- Minor Study sites: 4 to 5
- Secondary endpoints revised (7)
- Minor Site contacts updated at 1 of 4 sitesv5
- Notable Enrollment target: 300 to 660v3
- Notable Eligibility criteria shortened, about 1 word
- Study sites: 5 to 4
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Prevalence of breast pain after Accelerated Partial Breast Radiotherapy (APBI)
Timeframe: 5 years
Prevalence of chest wall pain after Accelerated Partial Breast Radiotherapy (APBI)
Timeframe: 2-5 years
Secondary (7)
Dosimetric comparison
Acute skin reactions
Cosmetic outcomes after APBI
Ipsilateral breast event
Cause specific survival
Show 2 moreShow less
Disease free survival
Overall survival
Arms and interventions
IMRTExperimental
Intensity modulated radiotherapy, 38.5 Gy, 10 fractions over 5 days
3D-CRTActive comparator
Three dimensional conformal external radiotherapy, 38.5 Gy, 10 fractions over 5 days
Radiation: accelerated partial breast irradiation - 3D-conformal planning, accelerated partial breast irradiation - IMRT planning
Sites
5 sites in 1 country